ストックスクリーナーアプリを入手
0.7644
0.36%
-0.0028
前日終値:
$0.7672
開ける：
$0.7974
24時間の取引高:
38,058
Relative Volume:
0.38
時価総額：
$13.89M
収益：
-
当期純損益:
$-26.56M
株価収益率:
-1.176
EPS:
-0.65
ネットキャッシュフロー:
$-22.29M
1週間 パフォーマンス:
+3.44%
1か月 パフォーマンス:
+23.29%
6か月 パフォーマンス:
-74.09%
1年 パフォーマンス:
-64.66%
1日の値動き範囲:
$0.734
$0.7974
1週間の範囲:
$0.7201
$0.7974
52週間の値動き範囲:
$0.48
$8.55
BiomX Inc Stock (PHGE) Company Profile
名前
BiomX Inc
セクター
電話
972 7 23942377
住所
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
PHGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.7644 | 13.89M | 0 | -26.56M | -22.29M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-04-15 | 開始されました | Ladenburg Thalmann | Buy |
BiomX Inc (PHGE) 最新ニュース
Barclays PLC Sells 225,000 Shares of BiomX Inc. (NYSEMKT:PHGE) - Defense World
HC Wainwright Reaffirms Buy Rating for BiomX (NYSEAMERICAN:PHGE) - Defense World
BiomX (NYSEMKT:PHGE) Stock Price Down 1.3% – Here’s Why - Defense World
BitMart Research: BMX 2024 Annual Report - GlobeNewswire Inc.
BiomX Inc. Regains Compliance with NYSE American Listing Standards - Defense World
BiomX regains NYSE compliance - Investing.com
BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards - The Manila Times
BiomX Regains NYSE American Listing Compliance After Meeting All Standards - StockTitan
BiomX (NYSEAMERICAN:PHGE) Stock Price Down 12.2% – Should You Sell? - Defense World
BiomX (PHGE) 5-Day RSI : 13.43 (As of Nov. 20, 2024) - GuruFocus.com
BiomX Announces Third Quarter 2024 Financial Results and Clinical Program Updates - Defense World
Biomx stock plunges to 52-week low, hits $0.61 - Investing.com India
Biomx stock plunges to 52-week low, hits $0.61 By Investing.com - Investing.com Canada
BiomX shares hold Buy rating from H.C. Wainwright on Q3 results - Investing.com Canada
BiomX Inc. (AMEX:PHGE) Q3 2024 Earnings Call Transcript - Insider Monkey
BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net In - GuruFocus.com
BiomX Inc. Reports Q3 2024 Financial Turnaround - TipRanks
BiomX Inc (PHGE) Quarterly 10-Q Report - Quartzy
BiomX Inc (PHGE) Reports Q3 2024 Net Income of $9.6 Million Amid Increased R&D and Administrative Expenses - GuruFocus.com
BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates - The Manila Times
BiomX Completes Trial Enrollment, Reports $9.6M Net Income in Q3 Despite Program Delays | PHGE Stock News - StockTitan
BiomX (NYSEMKT:PHGE) Trading 4.6% Higher – Time to Buy? - Defense World
BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024 - GlobeNewswire
Biomx stock plunges to 52-week low of $0.72 amid market challenges By Investing.com - Investing.com South Africa
Biomx stock plunges to 52-week low of $0.72 amid market challenges - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Trading Down 2.3%Here's Why - MarketBeat
BiomX announces a mandatory unit separation - MSN
BiomX announces mandatory unit separation - Yahoo Finance
BiomX Announces a Mandatory Unit Separation - The Manila Times
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ... - Yahoo Finance
BiomX (NYSEAMERICAN:PHGE) Shares Down 1.5% – What’s Next? - Defense World
Biomx stock plunges to 52-week low, hitting $0.92 - Investing.com
Biomx stock plunges to 52-week low, hitting $0.92 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Stock Price Down 1% - Defense World
BiomX Shares Phage Therapy Advances and Vision - TipRanks
Bacteriophages Therapy Market Size, Share And Growth Analysis - openPR
BiomX Stock Gains From Favorable Study Data Presentation on BX004 - Yahoo Finance
BiomX to present data from Phase 1b/2a study of BX004 - TipRanks
BiomX to Provide Latest Update on Positive Phase 1b/2a - GlobeNewswire
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference - StockTitan
Biomx stock plunges to 52-week low, hits $1.05 - Investing.com
BiomX (NYSEMKT:PHGE) Trading Down 5.4% - MarketBeat
BiomX (NYSEMKT:PHGE) Shares Down 5.4% - Defense World
Bacteriophage Therapy Market Projected To Witness Substantial Growth, 2024-2031: Enbiotix, Inc., Nextbiotics, - EIN News
BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
PHGEBiomX Inc. Latest Stock News & Market Updates - StockTitan
Biomx stock plunges to 52-week low at $1.15 amid market challenges - Investing.com
BiomX Inc (PHGE) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):